ArticleOncotarget2018

MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression.

Fangqiu Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.